eLaws | eCases | United States Code | Federal Courts |

AstraZeneca - Comment

Document ID: FDA-2011-D-0436-0004
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: August 25 2011, at 12:00 AM Eastern Daylight Time
Date Posted: September 7 2011, at 12:00 AM Eastern Standard Time
Comment Start Date: June 29 2011, at 12:00 AM Eastern Standard Time
Comment Due Date: September 1 2011, at 11:59 PM Eastern Standard Time
Tracking Number: 80eeffb3
View Document:

This is comment on Notice

Draft Guidance on Q11 Development and Manufacture of Drug Substances; Availability: International Conference on Harmonisation

View Comment

see attachments

Attachments:

AstraZeneca - Comment

Title:
AstraZeneca - Comment

View Attachment:

View as format pdf

Related Comments

View All

Total: 23

AstraZeneca - Comment
Public Submission Posted: 09/07/2011 ID: FDA-2011-D-0436-0004

Comment Period Closed
Sep 01,2011 11:59 PM ET

MedImmune - Comment
Public Submission Posted: 09/07/2011 ID: FDA-2011-D-0436-0005

Comment Period Closed
Sep 01,2011 11:59 PM ET

Johnson and Johnson Pharmaceutical Research and Development, LLC - Comment
Public Submission Posted: 09/07/2011 ID: FDA-2011-D-0436-0006

Comment Period Closed
Sep 01,2011 11:59 PM ET

Pfizer Inc. - Comment
Public Submission Posted: 09/07/2011 ID: FDA-2011-D-0436-0007

Comment Period Closed
Sep 01,2011 11:59 PM ET

Shire Pharmaceuticals Inc. - Comment
Public Submission Posted: 09/07/2011 ID: FDA-2011-D-0436-0008

Comment Period Closed
Sep 01,2011 11:59 PM ET